ORUKA THERAPEUTICS, INC. (ORKA) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-04-14
4:38 pm
Purchase
2022-04-1213DARCA BIOPHARMA INC PAR $.0
ABIO
Funicular Fund LP180,925
15.060%
18,842increase
(+11.62%)
Filing
History
2022-04-04
5:10 pm
Purchase
2022-03-3113DARCA BIOPHARMA INC PAR $.0
ABIO
Funicular Fund LP162,083
13.500%
84,163increase
(+108.01%)
Filing
History
2022-03-28
4:20 pm
Purchase
2022-03-1813DARCA BIOPHARMA INC PAR $.0
ABIO
Funicular Fund LP77,920
6.490%
77,920increase
(New Position)
Filing
History
2022-01-27
3:53 pm
Purchase
2022-01-2413GARCA BIOPHARMA INC PAR $.0
ABIO
BML Investment Partners, L.P.63,488
5.300%
63,488increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2